Use of perflubron emulsion to decrease allogeneic blood transfusion in high-blood-loss non-cardiac surgery: results of a European phase 3 study.
The authors should be commended for carrying out an elaborate multicenter study in such an elegant fashion. The Methods are well described, the statistics appropriate and the Results are presented according to the highest standards for a randomized controlled trial (intent-to-treat, post-hoc analyses, etc.). The study highlights the following points: augmented ANH will only be […]
